| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.54 | 0.005 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.24 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.19 | 0.4 |